A Phase I Study of a New Nucleoside Analogue, OSI-7836, Using Two Administration Schedules in Patients with Advanced Solid Malignancies by LEE, Chooi P, DE JONGE, Maja J. A, KAYE, Stan B, JUDSON, Ian R, VERWEIJ, Jaap, O'DONNELL, Anne E, SCHOTHORST, Kristel L, HANWELL, Janet, CHICK, Jon B, BROOIMANS, Rik A, ADAMS, Laurel M, DROLET, Daniel W, DE BONO, Johann S

Get full text